select a format

Single User License
USD 2500 INR 160725
Site License
USD 5000 INR 321450
Corporate User License
USD 7500 INR 482175

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Atrial Flutter Global Clinical Trials Review, H1, 2015

Atrial Flutter Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2612CTIDB
  • |
  • Pages: 89
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Atrial Flutter Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Atrial Flutter Global Clinical Trials Review, H1, 2015" provides data on the Atrial Flutter clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrial Flutter. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atrial Flutter. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Atrial Flutter 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Atrial Flutter to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Atrial Flutter to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Atrial Flutter 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Atrial Flutter Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Sanofi 31

Clinical Trial Overview of Sanofi 31

Cardiome Pharma Corp 32

Clinical Trial Overview of Cardiome Pharma Corp 32

Astellas Pharma Inc. 33

Clinical Trial Overview of Astellas Pharma Inc. 33

Abbott Laboratories 34

Clinical Trial Overview of Abbott Laboratories 34

Portola Pharmaceuticals, Inc. 35

Clinical Trial Overview of Portola Pharmaceuticals, Inc. 35

Bristol-Myers Squibb Company 36

Clinical Trial Overview of Bristol-Myers Squibb Company 36

Biotronik SE & Co. KG 37

Clinical Trial Overview of Biotronik SE & Co. KG 37

Bayer AG 38

Clinical Trial Overview of Bayer AG 38

ARCA biopharma, Inc. 39

Clinical Trial Overview of ARCA biopharma, Inc. 39

Aop Orphan Pharmaceuticals AG 40

Clinical Trial Overview of Aop Orphan Pharmaceuticals AG 40

Clinical Trial Overview of Top Institutes / Government 41

Qilu hospital 41

Clinical Trial Overview of Qilu hospital 41

Academia Sinica 42

Clinical Trial Overview of Academia Sinica 42

Albert-Ludwigs-Universitat Freiburg 43

Clinical Trial Overview of Albert-Ludwigs-Universitat Freiburg 43

Assistance Publique-Hopitaux de Paris 44

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 44

Brigham and Women's Hospital 45

Clinical Trial Overview of Brigham and Women's Hospital 45

CAMC Health System 46

Clinical Trial Overview of CAMC Health System 46

Cardioangiologischen Centrum Bethanien 47

Clinical Trial Overview of Cardioangiologischen Centrum Bethanien 47

Centre Hospitalier Universitaire-Hopitaux de Rouen 48

Clinical Trial Overview of Centre Hospitalier Universitaire-Hopitaux de Rouen 48

Centre Hospitalier Universitaire de Saint Etienne 49

Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 49

Department of Health, South Africa 50

Clinical Trial Overview of Department of Health, South Africa 50

Five Key Clinical Profiles 51

Appendix 87

Abbreviations 87

Definitions 87

Research Methodology 88

Secondary Research 88

About GlobalData 89

Contact Us 89

Disclaimer 89

Source 89

List of Figures

Atrial Flutter Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Atrial Flutter Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Atrial Flutter Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Atrial Flutter Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Atrial Flutter Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Atrial Flutter Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Atrial Flutter Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Atrial Flutter Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Atrial Flutter to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Atrial Flutter Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Atrial Flutter Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Atrial Flutter to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Atrial Flutter Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Atrial Flutter Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Atrial Flutter Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Atrial Flutter Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Atrial Flutter Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Atrial Flutter Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Atrial Flutter Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Atrial Flutter Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Atrial Flutter Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Atrial Flutter Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Atrial Flutter Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 88

List of Tables

Atrial Flutter Therapeutics, Global, Clinical Trials by Region, 2015* 7

Atrial Flutter Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Atrial Flutter Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Atrial Flutter Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Atrial Flutter Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Atrial Flutter Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Atrial Flutter Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Atrial Flutter Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Atrial Flutter to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Atrial Flutter Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Atrial Flutter Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Atrial Flutter to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Atrial Flutter Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Atrial Flutter Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Atrial Flutter Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Atrial Flutter Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Atrial Flutter Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Atrial Flutter Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Atrial Flutter Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Atrial Flutter Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Atrial Flutter Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Atrial Flutter Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Atrial Flutter Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Atrial Flutter Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 31

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiome Pharma Corp, 2015* 32

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 33

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 34

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Portola Pharmaceuticals, Inc., 2015* 35

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 36

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2015* 37

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 38

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCA biopharma, Inc., 2015* 39

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Aop Orphan Pharmaceuticals AG, 2015* 40

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Qilu hospital, 2015* 41

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Academia Sinica, 2015* 42

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert-Ludwigs-Universitat Freiburg, 2015* 43

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 44

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2015* 45

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by CAMC Health System, 2015* 46

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardioangiologischen Centrum Bethanien, 2015* 47

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire-Hopitaux de Rouen, 2015* 48

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2015* 49

Atrial Flutter Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Atrial Flutter Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Atrial Flutter, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com